Table 4 Baseline characteristics of patient in the treatment failure group vs. the no treatment failure group
Variables | Failure (n = 4) | No failure (n = 271) | p value* % | ||
|---|---|---|---|---|---|
N | % | N | % | ||
Median age [range] | 65.5 [45–87] | 57.0 [18–99] | 0.37 | ||
Race | |||||
White | 3 | 75.0 | 101 | 37.3 | 0.04 |
Black | 0 | 0.0 | 152 | 56.1 | |
Asian | 0 | 0.0 | 5 | 1.9 | |
Other/unknown | 1 | 25.0 | 13 | 4.8 | |
Co-morbidity | |||||
Median Charlson index [range] | 0 [0–2] | 0 [0–2] | 0.19 | ||
Having at least one Charlson conditions | 2 | 50.0 | 60 | 22.1 | 0.22 |
Acute myocardial infarction | 1 | 25.0 | 4 | 1.5 | 0.07 |
Congestive heart failure | 0 | 0.0 | 11 | 4.1 | 0.99 |
Peripheral vascular disease | 0 | 0.0 | 6 | 2.2 | 0.99 |
Cerebrovascular disease | 2 | 50.0 | 12 | 4.4 | 0.01 |
Dementia | 0 | 0 | 3 | 1.1 | 0.99 |
COPD | 0 | 0 | 15 | 5.5 | 0.99 |
Rheumatoid disease | 0 | 0 | 1 | 0.4 | 0.99 |
Peptic ulcer | 0 | 0 | 1 | 0.4 | 0.99 |
Mild liver disease | 0 | 0 | 1 | 0.4 | 0.99 |
Moderate/severe liver disease | 0 | 0 | 0 | 0 | – |
Diabetes | 0 | 0 | 4 | 1.5 | 0.99 |
Hemiplegia or paraplegia | 0 | 0 | 1 | 0.4 | 0.99 |
Renal disease | 0 | 0 | 8 | 3.0 | 0.99 |
Cancer | 0 | 0 | 13 | 4.8 | 0.99 |
Metastatic cancer | 0 | 0 | 7 | 2.5 | 0.99 |
AIDS | 0 | 0 | 0 | 0 | – |